NCT00810862View on ClinicalTrials.gov

Study of Pimecrolimus Treatment for Atopic Dermatitis of African American Children

PHASE4TerminatedINTERVENTIONAL
Enrollment

18

Participants

Timeline

Start Date

November 30, 2006

Primary Completion Date

June 30, 2008

Study Completion Date

June 30, 2008

Conditions
Atopic Dermatitis
Interventions
DRUG

pimecrolimus active cream

Pimecrolimus 1% cream apply to affected study area twice daily for 21 days

OTHER

placebo base cream

apply to affected study area twice daily for 21 days

Sponsors

Collaborators (1)

Novartis Pharmaceuticals
All Listed Sponsors
collaborator

Novartis Pharmaceuticals

INDUSTRY

lead

Children's Hospital of Michigan

OTHER